DRIVing Simulator and People With NeuroCognitive Disorders

Last updated: March 18, 2024
Sponsor: University Gustave Eiffel
Overall Status: Active - Recruiting

Phase

N/A

Condition

Neurologic Disorders

Treatment

N/A

Clinical Study ID

NCT06320639
UGustaveEiffel
  • Ages 50-95
  • All Genders

Study Summary

The ageing of the population is leading to an increasing number of older drivers on the roads. At the same time, the proportion of older people with pathological ageing and neurocognitive disorders (NCD) is increasing. In terms of road safety, this raises the question of whether these drivers should continue to drive or not. People with NCDs may not be aware of the presence, extent and progression of their cognitive impairment and the impact it can have on daily life, including driving.

Despite their loss of autonomy and medical advice, 22% of people with major NCD continue to drive. In addition, the presence of minor NCD also puts people at a higher risk of road accidents.

However, several studies demonstrated that an NCD does not lead to a systematic and immediate impairment of driving ability and abruptly stopping driving leads to health problems, such as the risk of depression and greatly reduces quality of life.

It is therefore relevant to focus research on driving with people with NCD in order to have a reliable indicator of the person's abilities and the impact of their cognitive impairment on driving activity. The proposed study seeks to meet this need by studying the performance of people with NCD on a driving station (mini-simulator) while assessing their ability to evaluate their performance.

To achieve this goal, people with NCDs will perform tasks on a driving simulator. In addition, after each task on the driving simulator, they will answer questions about how they evaluate their own driving. Two assessors will observe the participants' driving and will estimate their driving performance. By comparing the driver's self-assessment with the assessors' assessment, an "awareness score of driving ability" will be calculated to determine whether the driver correctly assessed his or her performance.

Another project already underway aims to collect similar data from people without a diagnosis of NCDs (control group).

The principal objective of the present study is to compare the driving performance in a simulator and the awareness of driving ability of people with NCDs with those of a control group. Secondary objectives are :

  1. to measure driving performance in a simulator and awareness of driving abilities (i.e. self-assessment skills) of people with NCDs.

  2. to analyse driving performance and awareness of driving abilities according to the diagnosis and severity of the disorder (i.e. minor or major neurocognitive disorders).

  3. to establish a methodology to identify a driver at risk of dangerous driving.

It is mainly an exploratory study however some hypotheses can be made :

  • The driving performance and awareness of driving skills of people with NCDs are poorer compared to those of older, control individuals.

  • Individuals' driving performance and awareness of driving ability are lower in the presence of major NCDs compared to minor NCDs.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosed with Neurocognitive Disorders according to the Diagnostic and StatisticalManual of Mental Disorders-V (DSM-V)
  • Normal or corrected vision
  • B licence holder with 3+ years driving experience
  • Active drivers or drivers who stopped driving less than 2 months ago (time between themedical consultation and the day in the day care hospital)
  • For participants able to give consent:
  • Written informed consent to participate in the study
  • Informed consent of the participant in the presence of his/her curator.
  • For participants who are not able to receive information and to give consent:
  • Written informed consent of the legal representative (tutor) for participantsunder tutelage.
  • Signature of a relative (family member and/or trusted person) of the participant
  • The participant has to be affiliated to a social security scheme.

Exclusion

Exclusion Criteria:

  • History of epilepsy
  • People with vestibular disorders, motion sickness or migraines
  • Psychiatric history (e.g. schizophrenia)
  • Non-stabilized use of antidepressants and/or anxiolytics (started or modified withinthe last 3 months)
  • History of alcoholism
  • Use of anti-epileptics
  • Osteo-articular pathologies compromising walking

Study Design

Total Participants: 150
Study Start date:
October 03, 2023
Estimated Completion Date:
October 10, 2026

Connect with a study center

  • Hôpital des Charpennes

    Villeurbanne, 69100
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.